News

Anticipating Theratechnologies' First Quarter Financial Announcement

Anticipating Theratechnologies' First Quarter Financial Announcement

Upcoming Financial Results for Theratechnologies

Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a leading force in the biopharmaceutical sector, is gearing up to announce its financial results for the first quarter of 2025. This significant update is scheduled for Wednesday, April 9, 2025, at 8:30 a.m. ET.

What to Expect During the Announcement

The company’s President and Chief Executive Officer, Paul Lévesque, will take the lead on this call. He will be joined by key members of the management team, including Philippe Dubuc, Senior Vice President and Chief Financial Officer, alongside Christian Marsolais, Ph.D., Senior Vice President and Chief Medical Officer, and John Leasure, Global Commercial Officer. Their collective expertise ensures that stakeholders will receive insightful commentary regarding the Company’s performance.

Conference Call Participation Details

Theratechnologies encourages participants to join the call at least ten minutes early for a smooth entry. Once dialed in, attendees will hear prepared remarks, followed by a session for questions and answers, providing an excellent opportunity to engage with the executive team directly.

Additional Details on the Conference Call

For those interested in participating, here's the essential information to note:

  • Date: April 9, 2025
  • Time: 8:30 a.m. ET
  • Dial-in Number: 1-877-513-4119 (toll-free) or 1-412-902-6615 (international)
  • Access Code: 2419339

Webcast Availability

If you can’t join live, an archived version of the conference will be accessible after the event through the Company’s Investor Relations website. Listening to the playback allows investors and interested parties to catch up on the details they may have missed.

Company Background

Theratechnologies is dedicated to transforming healthcare through innovative biopharmaceutical products. Their focus on developing unique therapies positions them to redefine care standards within their specialty area. As they continue to push the envelope, the forthcoming financial results are bound to spark interest among investors and healthcare professionals alike.

Expansion and Innovation

In recent times, Theratechnologies has made remarkable strides in expanding its portfolio of treatments, enhancing its research capabilities, and fostering partnerships that strengthen its market position. The coming announcement is expected to highlight the success of these initiatives, further demonstrating the Company’s commitment to holistic growth in the biopharmaceutical landscape.

Frequently Asked Questions

1. When will Theratechnologies announce its Q1 2025 financial results?

The financial results will be announced on April 9, 2025, at 8:30 a.m. ET.

2. Who will be hosting the conference call?

Paul Lévesque, the President and CEO, will host the call, accompanied by key members of the management team.

3. How can participants access the conference call?

Participants can dial in using the toll-free number 1-877-513-4119 or the international number 1-412-902-6615.

4. Is there a replay option for those who miss the call?

Yes, a replay of the conference call will be available through the Company’s Investor Relations website.

5. Where can I find more information about Theratechnologies?

For additional insights, visit the Company's official website to explore further details about their products and initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

EEW Renewables and CDAQ Plan Major Business Move Together

Updated Category News Views 57

EEW Renewables and CDAQ Unveil Investor Webcast for Business Combination EEW Renewables Ltd, a leader in the renewable energy sector, has teamed up with Compass Digital Acquisition Corp, commonly known as CDAQ, to announce the release of an investor webcast aimed at discussing their proposed business combination. The webcast features insightful presentations from the...

Continue Reading
Investors Can Take Action in Integer Holdings Lawsuit Today

Updated Category News Views 131

Opportunities for Integer Holdings Investors Recently, Integer Holdings Corporation (NYSE: ITGR) has opened the door for investors to engage actively in a securities fraud lawsuit. This comes as the Rosen Law Firm, known for its expertise in investor rights, brought attention to a class action concerning common stock purchases made between July 25, 2024 and October 22,...

Continue Reading
Controversial Legal Battle Unfolds at FNZ Amid Equity Tensions

Updated Category News Views 365

FNZ Directors Face Employee Shareholder Backlash In a surprising twist in the ongoing legal saga surrounding FNZ, the two directors representing major shareholders have taken significant steps to impede a USD $4.6 billion class action initiated by employee shareholders. This action raises serious concerns about corporate governance and the rights of employees within the...

Continue Reading
Unity in the Cannabis Industry: A New Path Forward

Updated Category News Views 88

Time for Unity in the Cannabis Industry Recent changes in the hemp and cannabis industries have underscored how vital collaboration is. Experts in the field are pushing for a stronger partnership between these sectors to advocate for clear and coherent federal regulations. The Current Situation Tensions are rising across several states. For instance, Florida's hemp...

Continue Reading
Daiso Launches New Store in San Antonio's Shopping Hub

Updated Category News Views 314

Exciting New Daiso Store Opening Daiso, a global retail sensation, is set to debut its latest store at Thousand Oaks Shopping Center. This opening is generating buzz among shoppers looking for affordable and unique merchandise. The store is designed to cater to a diverse range of tastes and needs, and it's perfectly timed for the upcoming shopping season. Store Features...

Continue Reading